Castle Biosciences, Inc. (CSTL)
33.50
-0.70
(-2.05%)
USD |
NASDAQ |
Aug 24, 16:00
33.50
0.00 (0.00%)
After-Hours: 20:00
Castle Biosciences Total Liabilities (Quarterly) : 91.15M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 91.15M |
| March 31, 2026 | 86.39M |
| December 31, 2025 | 138.34M |
| September 30, 2025 | 95.74M |
| June 30, 2025 | 89.35M |
| March 31, 2025 | 61.41M |
| December 31, 2024 | 98.08M |
| September 30, 2024 | 73.51M |
| June 30, 2024 | 63.42M |
| March 31, 2024 | 56.04M |
| December 31, 2023 | 86.54M |
| September 30, 2023 | 50.24M |
| June 30, 2023 | 46.63M |
| March 31, 2023 | 41.74M |
| December 31, 2022 | 74.87M |
| Date | Value |
|---|---|
| September 30, 2022 | 46.38M |
| June 30, 2022 | 36.72M |
| March 31, 2022 | 47.09M |
| December 31, 2021 | 50.83M |
| September 30, 2021 | 21.98M |
| June 30, 2021 | 19.62M |
| March 31, 2021 | 18.74M |
| December 31, 2020 | 23.64M |
| September 30, 2020 | 43.84M |
| June 30, 2020 | 43.92M |
| March 31, 2020 | 32.32M |
| December 31, 2019 | 34.63M |
| September 30, 2019 | 30.86M |
| June 30, 2019 | 38.44M |
| March 31, 2019 | 35.35M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| RadNet, Inc. | 2.832B |
| Lumexa Imaging Holdings, Inc. | 1.194B |
| Labcorp Holdings, Inc. | 9.909B |
| Quest Diagnostics, Inc. | 9.04B |
| OPKO Health, Inc. | 645.29M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 561.18M |
| Shareholders Equity (Quarterly) | 470.03M |
| Debt to Equity Ratio | 0.078 |
| Current Ratio | 6.036 |
| Net Debt Paydown Yield | -0.30% |